NCT02804035View on ClinicalTrials.gov

Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Heart Failure
Interventions
COMBINATION_PRODUCT

sc2Wear Furosemide

Drug-device combination product of buffered furosemide injection, (Furosemide Injection Solution), 8 mg/mL, and patch pump (sc2Wear Furosemide Pump)

All Listed Sponsors
lead

scPharmaceuticals, Inc.

INDUSTRY

NCT02804035 - Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product | Biotech Hunter | Biotech Hunter